02 9487 9111

Sydney Adventist Hospital
« View pages

Clinical Specialties - Cancer

Haematological Cancer Clinical Trials


Randomised double blind placebo controlled phase 3 study of the Bruton's Tyrosine Kinase Inhibitor PCI 32765 (Ibrutinib) in combination with either Bendamustine and Rituximab or Rituximab, Cyclophosphamide , Doxorubicin, Vincristine and Prednisone (RCHOP) in subjects with previously treated indolent NHL



An Australian, phase II, multicentre, randomised, study investigating safety and efficacy for dose reduced fludarabine, cyclophosphamide and i.v. obinutuzumab (G-FC3) versus oral chlorambucil and i.v. obinutuzumab (G-Clb) in previously untreated, comorbid (CIRS score ≥6), elderly (≥65 years old) patients with chronic lymphocytic leukaemia (CLL)


Back to Top

Sydney Adventist Hospital Clinical Specialties and Services